In The News,
Launch Planning and Implementation Support for Novel Biologic
ADVI helped management design and execute a series of interlocking P&R and market access imperatives that include global pricing policy, Core Value Dossier (CVD), transition from special license sales programs to full market access, ongoing support of internal P&R needs of senior management and affiliates, pricing database to monitor developments in other high-profile launches, decision support tool to prioritize the optimal P&R and launch sequence strategy, P&R implications of follow-on indications.